 | • レポートコード：C9OT0903 • 出版社/出版日：Prof Research / 2019年10月1日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・バイオ |
| Single User | ￥420,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥532,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ベバシズマブ・バイオシミラー市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるベバシズマブ・バイオシミラー市場について調査・分析したレポートで、ベバシズマブ・バイオシミラーの世界市場動向、市場規模、主要企業情報などが含まれています。ベバシズマブ・バイオシミラーのタイプ別には、100mg、400mgに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・ベバシズマブ・バイオシミラー産業の概要 ・ベバシズマブ・バイオシミラーの製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のベバシズマブ・バイオシミラー市場 2014年-2019年 ・世界及び中国のベバシズマブ・バイオシミラー市場現状 ・企業別分析：Pfizer, Allergan, Alnylam Pharmaceuticals, Amgen, Angstrom Pharmaceuticals, Acceleron Pharma, Biocon, Bionomics, CASI Pharmaceuticals, Celgene Corporation, Enzon Pharmaceuticals, Five Prime Therapeutiなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・タイプ別分析：100mg、400mg ・世界及び中国のベバシズマブ・バイオシミラー市場予測 2019年-2024年 ・ベバシズマブ・バイオシミラーの産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のベバシズマブ・バイオシミラー市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Bevacizumab Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bevacizumab Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bevacizumab Biosimilar manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Bevacizumab Biosimilar market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Bevacizumab Biosimilar industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Bevacizumab Biosimilar industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Bevacizumab Biosimilar Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Bevacizumab Biosimilar as well as some small players. At least 12 companies are included:
* Pfizer
* Allergan
* Alnylam Pharmaceuticals
* Amgen
* Angstrom Pharmaceuticals
* Acceleron Pharma
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Bevacizumab Biosimilar market in gloabal and china.
* 100mg
* 400mg
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Estimates 2019-2024 Bevacizumab Biosimilar market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Bevacizumab Biosimilar Industry
1.1 Brief Introduction of Bevacizumab Biosimilar
1.2 Development of Bevacizumab Biosimilar Industry
1.3 Status of Bevacizumab Biosimilar Industry
Chapter Two Manufacturing Technology of Bevacizumab Biosimilar
2.1 Development of Bevacizumab Biosimilar Manufacturing Technology
2.2 Analysis of Bevacizumab Biosimilar Manufacturing Technology
2.3 Trends of Bevacizumab Biosimilar Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Allergan
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Alnylam Pharmaceuticals
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Amgen
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Angstrom Pharmaceuticals
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Acceleron Pharma
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Biocon
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Bevacizumab Biosimilar
4.1 2014-2019 Global Capacity, Production and Production Value of Bevacizumab Biosimilar Industry
4.2 2014-2019 Global Cost and Profit of Bevacizumab Biosimilar Industry
4.3 Market Comparison of Global and Chinese Bevacizumab Biosimilar Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Bevacizumab Biosimilar
4.5 2014-2019 Chinese Import and Export of Bevacizumab Biosimilar
Chapter Five Market Status of Bevacizumab Biosimilar Industry
5.1 Market Competition of Bevacizumab Biosimilar Industry by Company
5.2 Market Competition of Bevacizumab Biosimilar Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Bevacizumab Biosimilar Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Bevacizumab Biosimilar Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Bevacizumab Biosimilar
6.2 2019-2024 Bevacizumab Biosimilar Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Bevacizumab Biosimilar
6.4 2019-2024 Global and Chinese Supply and Consumption of Bevacizumab Biosimilar
6.5 2019-2024 Chinese Import and Export of Bevacizumab Biosimilar
Chapter Seven Analysis of Bevacizumab Biosimilar Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Bevacizumab Biosimilar Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Bevacizumab Biosimilar Industry
Chapter Nine Market Dynamics of Bevacizumab Biosimilar Industry
9.1 Bevacizumab Biosimilar Industry News
9.2 Bevacizumab Biosimilar Industry Development Challenges
9.3 Bevacizumab Biosimilar Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Bevacizumab Biosimilar Industry
Tables and Figures
Figure Bevacizumab Biosimilar Product Picture
Table Development of Bevacizumab Biosimilar Manufacturing Technology
Figure Manufacturing Process of Bevacizumab Biosimilar
Table Trends of Bevacizumab Biosimilar Manufacturing Technology
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
Figure Bevacizumab Biosimilar Product and Specifications
Table 2014-2019 Bevacizumab Biosimilar Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2014-2019 Bevacizumab Biosimilar Production Global Market Share
……
……
Table 2014-2019 Global Bevacizumab Biosimilar Capacity List
Table 2014-2019 Global Bevacizumab Biosimilar Key Manufacturers Capacity Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Manufacturers Capacity Share
Table 2014-2019 Global Bevacizumab Biosimilar Key Manufacturers Production List
Table 2014-2019 Global Bevacizumab Biosimilar Key Manufacturers Production Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Manufacturers Production Share
Figure 2014-2019 Global Bevacizumab Biosimilar Capacity Production and Growth Rate
Table 2014-2019 Global Bevacizumab Biosimilar Key Manufacturers Production Value List
Figure 2014-2019 Global Bevacizumab Biosimilar Production Value and Growth Rate
Table 2014-2019 Global Bevacizumab Biosimilar Key Manufacturers Production Value Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Manufacturers Production Value Share
Table 2014-2019 Global Bevacizumab Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Bevacizumab Biosimilar Production
Table 2014-2019 Global Supply and Consumption of Bevacizumab Biosimilar
Table 2014-2019 Import and Export of Bevacizumab Biosimilar
Figure 2018 Global Bevacizumab Biosimilar Key Manufacturers Capacity Market Share
Figure 2018 Global Bevacizumab Biosimilar Key Manufacturers Production Market Share
Figure 2018 Global Bevacizumab Biosimilar Key Manufacturers Production Value Market Share
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Capacity List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Capacity
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Capacity Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Capacity Share
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Production List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Production
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Production Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Production Share
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Consumption Volume List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Consumption Volume
Table 2014-2019 Global Bevacizumab Biosimilar Key Countries Consumption Volume Share List
Figure 2014-2019 Global Bevacizumab Biosimilar Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Bevacizumab Biosimilar Consumption Volume Market by Application
Table 89 2014-2019 Global Bevacizumab Biosimilar Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Bevacizumab Biosimilar Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Bevacizumab Biosimilar Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Bevacizumab Biosimilar Consumption Volume Market by Application
Figure 2019-2024 Global Bevacizumab Biosimilar Capacity Production and Growth Rate
Figure 2019-2024 Global Bevacizumab Biosimilar Production Value and Growth Rate
Table 2019-2024 Global Bevacizumab Biosimilar Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Bevacizumab Biosimilar Production
Table 2019-2024 Global Supply and Consumption of Bevacizumab Biosimilar
Table 2019-2024 Import and Export of Bevacizumab Biosimilar
Figure Industry Chain Structure of Bevacizumab Biosimilar Industry
Figure Production Cost Analysis of Bevacizumab Biosimilar
Figure Downstream Analysis of Bevacizumab Biosimilar
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Bevacizumab Biosimilar Industry
Table Bevacizumab Biosimilar Industry Development Challenges
Table Bevacizumab Biosimilar Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Bevacizumab Biosimilars Project Feasibility Study
インターフェロンアルファ-2bバイオシミラー市場：世界及び中国市場分析・予測（～2024年） Interferon Alpha-2b Biosimilar Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Interferon Alpha-2b Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Interfer…- バイオシミラー市場：世界及び中国市場分析・予測（～2024年） Biosimilars Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilars industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilars manufacturers and is a valuable so…